← Leaderboards
Nicholas Borcherding
University Of Iowa
$143,438
Attributed
$143,438
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $42.4K · FY2017–20$50K$37.5K$25K$12.5K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$143,438 · 1
By mechanism
F30$143,438 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Epithelial”
- Gary Fanger · Rise Therapeutics, Llc$15,902,290
- Jakob H. Von Moltke · University Of Washington$8,146,800
- Shruti Naik · New York University School Of Medicine$6,937,612
- Birgit Schilling · Medical College Of Wisconsin$6,423,173
- Nicholas Arpaia · Columbia Univ New York Morningside$6,241,249
- Elizabeth Ann Sugar · Johns Hopkins University$6,179,197
Research focus
EpithelialAdultAffinityEmbryonic DevelopmentBindingBiochemical GeneticsBasal CellBreast CarcinomaBurden Of IllnessBeta CateninCancer InitiationCancer TypeCell GrowthCell PhysiologyCellsCell SurvivalCessation Of LifeClinical ManagementCrispr/Cas TechnologyDevelopmental ProcessDiestrusCancer CellEarly DiagnosisEpithelium
Grant awards (4)
The role of paracrine WNT5A/RYK in ErbB2-driven tumorigenesis$32,645
F30 · FY2020 · CA · contact PI
The role of paracrine WNT5A/RYK in ErbB2-driven tumorigenesis$42,379
F30 · FY2019 · CA · contact PI
The role of paracrine WNT5A/RYK in ErbB2-driven tumorigenesis$34,447
F30 · FY2018 · CA · contact PI
The role of paracrine WNT5A/RYK in ErbB2-driven tumorigenesis$33,967
F30 · FY2017 · CA · contact PI